Evidence map›Paper›PMID 20657837›Full record

ArticlePloS one2010

I-motif structures formed in the human c-MYC promoter are highly dynamic--insights into sequence redundancy and I-motif stability.

Jixun Dai, Emmanuel Hatzakis, Laurence H Hurley, Danzhou Yang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The interactions of Pu22 G-quadruplex, derived fromMolecular therapy. Nucleic acids · 2025
    Article
  6. Review
  7. Article
  8. Crystal Structure of an i-Motif from the HRAS Oncogene Promoter.Angewandte Chemie (International ed. in English) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jixun DaiCollege of Pharmacy, The University of Arizona, Tucson, Arizona, United States of America.
Emmanuel Hatzakis
Laurence H Hurley
Danzhou Yang
University of Arizona · US

Funding

G-quadruplexes formed in human oncogene promoters and their drug complexesR01CA122952 · NCI · UNIVERSITY OF ARIZONA · PI YANG, DANZHOU · 2007 to 2011
$875k
Acquisition of a Bruker 600MHz NMR SpectrometerS10RR016659 · NCRR · UNIVERSITY OF ARIZONA · PI YANG, DANZHOU · 2002 to 2002
$393k
NCI NIH HHS CA122952NCI NIH HHS R01 CA122952NCRR NIH HHS 1S10 RR16659
6 · The paper itself

Abstract

The GC-rich nuclease hypersensitivity element III1 (NHE III1) of the c-MYC promoter largely controls the transcriptional activity of the c-MYC oncogene. The C-rich strand in this region can form I-motif DNA secondary structures. We determined the folding pattern of the major I-motif formed in the NHE III1, which can be formed at near-neutral pH. While we find that the I-motif formed in the four 3' consecutive runs of cytosines appears to be the most favored, our results demonstrate that the C-rich strand of the c-MYC NHE III1 exhibits a high degree of dynamic equilibration. Using a trisubstituted oligomer of this region, we determined the formation of two equilibrating loop isomers, one of which contains a flipped-out cytosine. Our results indicate that the intercalative cytosine+-cytosine base pairs are not always necessary for an intramolecular I-motif. The dynamic character of the c-MYC I-motif is intrinsic to the NHE III1 sequence and appears to provide stability to the c-MYC I-motif.

Indexed as

Base SequenceHumansMagnetic Resonance SpectroscopyNucleic Acid ConformationPromoter Regions, GeneticProto-Oncogene Proteins c-mycMYC protein, humanProto-Oncogene Proteins c-myc

Identifiers

PMID20657837
PMCPMC2906509
OpenAlexW2031205304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.